![Malcolm L. McConville](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Malcolm L. McConville
Nessuna posizione attualmente
Profilo
Malcolm L.
McConville worked as a Development Director at AmpliPhi Biosciences Corp.
and as a Development Manager at Biocontrol Ltd.
(United Kingdom).
He holds a doctorate degree from The University of Reading and an undergraduate degree from the University of Cardiff.
Precedenti posizioni note di Malcolm L. McConville
Società | Posizione | Fine |
---|---|---|
Biocontrol Ltd. (United Kingdom)
![]() Biocontrol Ltd. (United Kingdom) BiotechnologyHealth Technology Biocontrol Ltd. develops treatment to cure antibiotic resistant infections. The company was founded by David Harper on October 20, 1997 and is headquartered in Newbury, the United Kingdom. | Corporate Officer/Principal | - |
AmpliPhi Biosciences Corp.
![]() AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
Formazione di Malcolm L. McConville
University of Cardiff | Undergraduate Degree |
The University of Reading | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
AmpliPhi Biosciences Corp.
![]() AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | Health Technology |
Biocontrol Ltd. (United Kingdom)
![]() Biocontrol Ltd. (United Kingdom) BiotechnologyHealth Technology Biocontrol Ltd. develops treatment to cure antibiotic resistant infections. The company was founded by David Harper on October 20, 1997 and is headquartered in Newbury, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Malcolm L. McConville